ML18025B121: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
(2 intermediate revisions by the same user not shown)
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:NorthwestMedical IsotopesConstruction Permit Application Review*Mandatory Hearing (Overview Panel)*January 23, 2018 Panelists*Michele Evans-Deputy Director for Reactor Safety Programs and Mission Support, NRR*MaryJane Ross-Lee-Deputy Director, NRR/DLP*Joseph Donoghue-Deputy Director, NRR/DMLR*Brian Smith-Deputy Director, NMSS/FCSE2 99Mo Overview*99Mo decays to 99mTc-Effective diagnosis-Minimal exposure*50,000 procedures daily*No domestically-produced supply3 Establishing a Domestic Supply of 99Mo*NRC supports U.S. policy objectives to establish domestic 99Mo production*First construction permit for domestic 99Mo production issued to SHINE Medical Technologies in 2016*Northwest Medical Isotopes would produce 99Mo by processing irradiated low enriched uranium targets4 Conducting the NWMI Review*Review of NWMI application supported by procedural efficiencies and previous licensing experience-Two-part application submission-Document templates-Permit condition supporting quality assurance implementation*Staff and contractors spent ~12,000 hours reviewing NWMI application 5 Authorizing Construction*NWMI seeks authorization to construct 10 CFR Part 50 production facility*Staff review based on preliminary design and analysis of facility-Design details may be left for operating license application-Target fabrication activities to be considered under a 10 CFR Part 70 application6 Conducting the Safety Review7EnvironmentalReviewACRS ReviewMandatory HearingApplication Submitted to NRCCommission Decision on PermitSafetyReview Tailoring Review Methodology*Review accommodated unique aspects of the NWMI application*Staff adapted existing guidance for research reactors, production facilities, and fuel cycle facilities*Review focused on whether there was reasonable assurance that the final design would conform to design bases8 Additional Information*In response to staff requests, NWMI provided additional information*In some cases, permit conditions were necessary to support findings*Regulatory commitments track items for resolution in Final Safety Analysis Report9 EnvironmentalRequirements*National Environmental PolicyAct-Informs Federal decision making-Publicdisclosure*NRC environmentalregulations in       10 CFR Part 51-NRC regulations implementing the National Environmental Policy Act10 Environmental ReviewProcessEnvironmentalSiteAuditDraft  Environmental Impact  StatementScoping*Comment Period**Opportunity for Public InvolvementFinal  Environmental  Impact  StatementEnvironmentalReportRequestforAdditionalInformation11 Proposed Discovery RidgeSite12*Agriculturalland*Previouslydisturbed*No surface water features*No threatened or endangeredspecies*No historical or culturalresources Statutory and Regulatory Basis for Construction Permit Issuance*Commission authorized to issue permits by Atomic Energy Act, Section 103*Applicable requirements in                 10 CFR Parts 20, 50, and 51*Performance requirements in             10 CFR Part 70 also considered13 Construction Permit Findings*Preliminary facility design described*Further technical or design information may be left for FSAR*Ongoing research and development identified*Facility can be constructed and operated without undue risk14 Construction Permit Considerations*Construction will not endanger public health and safety*NWMI is technically and financially qualified*Environmental requirements have been satisfied15 Introducing the Review Panels16PanelNumberDiscussion TopicsEvaluationAreasSafety Panel 1Licensing ConsiderationsSafetyEvaluation ReportChapters1, 4, and 12Safety Panel 2Accident Analysis MethodologySafety Evaluation ReportChapter13Environmental Panel*Final EnvironmentalImpact Statement Process*Scope and Connected Actions*Analysis of AlternativesFinal Environmental Impact Statement Acronyms*NRR -Office of Nuclear Reactor Regulation*DLP -Division of Licensing Projects*DMLR-Division of Materials and License Renewal*NMSS-Office of Nuclear Material Safety and Safeguards*FCSE-Division of Fuel Cycle Safety, Safeguards, and Environmental Review17 Acronyms*99Mo-molybdenum-99*99mTc-technetium-99m*NRC-U.S. Nuclear Regulatory Commission*NWMI-Northwest Medical Isotopes*CFR-Code of Federal Regulations*ACRS-Advisory Committee on Reactor Safeguards*FSAR-final safety analysis report18}}
{{#Wiki_filter:NRC-010 Northwest Medical Isotopes Construction Permit Application Review
* Mandatory Hearing (Overview Panel)
* January 23, 2018             United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of:            NORTHWEST MEDICAL ISOTOPES, LLC (Medical Radioisotope Production Facility)
Commission Mandatory Hearing Docket #: 05000609 Exhibit #: NRC-010-MA-CM01                  Identified: 1/23/2018 Admitted: 1/23/2018                        Withdrawn:
Rejected:                                    Stricken:
Other:
 
Panelists
* Michele Evans
  - Deputy Director for Reactor Safety Programs and Mission Support, NRR
* MaryJane Ross-Lee
  - Deputy Director, NRR/DLP
* Joseph Donoghue
  - Deputy Director, NRR/DMLR
* Brian Smith
  - Deputy Director, NMSS/FCSE 2
 
99Mo Overview
* 99Mo   decays to 99mTc
  - Effective diagnosis
  - Minimal exposure
* 50,000 procedures daily
* No domestically-produced supply 3
 
Establishing a Domestic Supply of 99Mo
* NRC supports U.S. policy objectives to establish domestic 99Mo production
* First construction permit for domestic 99Mo production issued to SHINE Medical Technologies in 2016
* Northwest Medical Isotopes would produce 99Mo by processing irradiated low enriched uranium targets 4
 
Conducting the NWMI Review
* Review of NWMI application supported by procedural efficiencies and previous licensing experience
  - Two-part application submission
  - Document templates
  - Permit condition supporting quality assurance implementation
* Staff and contractors spent ~12,000 hours reviewing NWMI application 5
 
Authorizing Construction
* NWMI seeks authorization to construct 10 CFR Part 50 production facility
* Staff review based on preliminary design and analysis of facility
  - Design details may be left for operating license application
  - Target fabrication activities to be considered under a 10 CFR Part 70 application                        6
 
Conducting the Safety Review Safety Review ACRS Review Application Commission Submitted to NRC                      Mandatory Decision Hearing on Permit Environmental Review 7
 
Tailoring Review Methodology
* Review accommodated unique aspects of the NWMI application
* Staff adapted existing guidance for research reactors, production facilities, and fuel cycle facilities
* Review focused on whether there was reasonable assurance that the final design would conform to design bases 8
 
Additional Information
* In response to staff requests, NWMI provided additional information
* In some cases, permit conditions were necessary to support findings
* Regulatory commitments track items for resolution in Final Safety Analysis Report 9
 
Environmental Requirements
* National Environmental Policy Act
  - Informs Federal decision making
  - Public disclosure
* NRC environmental regulations in 10 CFR Part 51
  - NRC regulations implementing the National Environmental Policy Act 1
0
 
Environmental Review Process Environmental Report Draft                        Final Environmental               Comment Environmental                Environmental Site Audit                Period
* Impact                      Impact Statement                    Statement Scoping *
* Opportunity for Public Request for                Involvement Additional Information 1
1
 
Proposed Discovery Ridge Site
* Agricultural land
* Previously disturbed
* No surface water features
* No threatened or endangered species
* No historical or cultural resources 1
2
 
Statutory and Regulatory Basis for Construction Permit Issuance
* Commission authorized to issue permits by Atomic Energy Act, Section 103
* Applicable requirements in 10 CFR Parts 20, 50, and 51
* Performance requirements in 10 CFR Part 70 also considered 1
3
 
Construction Permit Findings
* Preliminary facility design described
* Further technical or design information may be left for FSAR
* Ongoing research and development identified
* Facility can be constructed and operated without undue risk 1
4
 
Construction Permit Considerations
* Construction will not endanger public health and safety
* NWMI is technically and financially qualified
* Environmental requirements have been satisfied 1
5
 
Introducing the Review Panels Panel Number      Discussion Topics    Evaluation Areas Safety Panel 1      Licensing            Safety Evaluation Considerations        Report Chapters 1, 4, and 12 Safety Panel 2      Accident Analysis     Safety Evaluation Methodology          Report Chapter 13 Environmental Panel
* Final Environmental Final Environmental Impact Statement  Impact Statement Process
* Scope and Connected Actions
* Analysis of Alternatives 1
6
 
Acronyms
* NRR - Office of Nuclear Reactor Regulation
* DLP - Division of Licensing Projects
* DMLR - Division of Materials and License Renewal
* NMSS - Office of Nuclear Material Safety and Safeguards
* FCSE - Division of Fuel Cycle Safety, Safeguards, and Environmental Review                        1 7
 
Acronyms
* 99Mo - molybdenum-99
* 99mTc - technetium-99m
* NRC - U.S. Nuclear Regulatory Commission
* NWMI - Northwest Medical Isotopes
* CFR - Code of Federal Regulations
* ACRS - Advisory Committee on Reactor Safeguards
* FSAR - final safety analysis report 1 8}}

Latest revision as of 02:32, 22 October 2019

Official Exhibit - NRC-010-MA-CM01 - Staff Presentation Slides - Overview (Jan. 16, 2018)
ML18025B121
Person / Time
Site: Northwest Medical Isotopes
Issue date: 01/16/2018
From:
NRC/OGC
To:
NRC/OCM
SECY RAS
References
50-609-CP, Construction Permit Mndtry Hrg, RAS 54173
Download: ML18025B121 (18)


Text

NRC-010 Northwest Medical Isotopes Construction Permit Application Review

  • Mandatory Hearing (Overview Panel)
  • January 23, 2018 United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of: NORTHWEST MEDICAL ISOTOPES, LLC (Medical Radioisotope Production Facility)

Commission Mandatory Hearing Docket #: 05000609 Exhibit #: NRC-010-MA-CM01 Identified: 1/23/2018 Admitted: 1/23/2018 Withdrawn:

Rejected: Stricken:

Other:

Panelists

- Deputy Director for Reactor Safety Programs and Mission Support, NRR

  • MaryJane Ross-Lee

- Deputy Director, NRR/DLP

- Deputy Director, NRR/DMLR

- Deputy Director, NMSS/FCSE 2

99Mo Overview

  • 99Mo decays to 99mTc

- Effective diagnosis

- Minimal exposure

  • 50,000 procedures daily
  • No domestically-produced supply 3

Establishing a Domestic Supply of 99Mo

  • NRC supports U.S. policy objectives to establish domestic 99Mo production
  • First construction permit for domestic 99Mo production issued to SHINE Medical Technologies in 2016
  • Northwest Medical Isotopes would produce 99Mo by processing irradiated low enriched uranium targets 4

Conducting the NWMI Review

  • Review of NWMI application supported by procedural efficiencies and previous licensing experience

- Two-part application submission

- Document templates

- Permit condition supporting quality assurance implementation

  • Staff and contractors spent ~12,000 hours0 days <br />0 hours <br />0 weeks <br />0 months <br /> reviewing NWMI application 5

Authorizing Construction

  • NWMI seeks authorization to construct 10 CFR Part 50 production facility
  • Staff review based on preliminary design and analysis of facility

- Design details may be left for operating license application

- Target fabrication activities to be considered under a 10 CFR Part 70 application 6

Conducting the Safety Review Safety Review ACRS Review Application Commission Submitted to NRC Mandatory Decision Hearing on Permit Environmental Review 7

Tailoring Review Methodology

  • Review accommodated unique aspects of the NWMI application
  • Staff adapted existing guidance for research reactors, production facilities, and fuel cycle facilities
  • Review focused on whether there was reasonable assurance that the final design would conform to design bases 8

Additional Information

  • In response to staff requests, NWMI provided additional information
  • In some cases, permit conditions were necessary to support findings
  • Regulatory commitments track items for resolution in Final Safety Analysis Report 9

Environmental Requirements

  • National Environmental Policy Act

- Informs Federal decision making

- Public disclosure

- NRC regulations implementing the National Environmental Policy Act 1

0

Environmental Review Process Environmental Report Draft Final Environmental Comment Environmental Environmental Site Audit Period

  • Impact Impact Statement Statement Scoping *
  • Opportunity for Public Request for Involvement Additional Information 1

1

Proposed Discovery Ridge Site

  • Agricultural land
  • Previously disturbed
  • No surface water features
  • No threatened or endangered species
  • No historical or cultural resources 1

2

Statutory and Regulatory Basis for Construction Permit Issuance

  • Commission authorized to issue permits by Atomic Energy Act, Section 103

3

Construction Permit Findings

  • Preliminary facility design described
  • Further technical or design information may be left for FSAR
  • Ongoing research and development identified
  • Facility can be constructed and operated without undue risk 1

4

Construction Permit Considerations

  • Construction will not endanger public health and safety
  • NWMI is technically and financially qualified
  • Environmental requirements have been satisfied 1

5

Introducing the Review Panels Panel Number Discussion Topics Evaluation Areas Safety Panel 1 Licensing Safety Evaluation Considerations Report Chapters 1, 4, and 12 Safety Panel 2 Accident Analysis Safety Evaluation Methodology Report Chapter 13 Environmental Panel

  • Final Environmental Final Environmental Impact Statement Impact Statement Process
  • Scope and Connected Actions
  • Analysis of Alternatives 1

6

Acronyms

  • NRR - Office of Nuclear Reactor Regulation
  • DLP - Division of Licensing Projects
  • NMSS - Office of Nuclear Material Safety and Safeguards
  • FCSE - Division of Fuel Cycle Safety, Safeguards, and Environmental Review 1 7

Acronyms

  • 99Mo - molybdenum-99
  • 99mTc - technetium-99m
  • NRC - U.S. Nuclear Regulatory Commission
  • NWMI - Northwest Medical Isotopes
  • CFR - Code of Federal Regulations
  • FSAR - final safety analysis report 1 8